Prof Saul Faust, who led the trial at University Hospital Southampton NHS Foundation Trust, said: “It’s really encouraging that a wide range of vaccines, using different technologies, show benefits as a third dose to either AstraZeneca or Pfizer-BioNTech. Source link
By Robert Preidt HealthDay Reporter THURSDAY, Dec. 2, 2021 (HealthDay News) — Which coronavirus vaccine is best at beating COVID-19 — Moderna or Pfizer? New research hands that honor to Moderna: In what is billed as the first head-to-head comparison of the two shots, researchers analyzed the health records of nearly 440,000 U.S. veterans … Read more
Nov. 30, 2021 — The Moderna CEO says existing COVID-19 vaccines will likely be less effective against the new Omicron variant. “There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Stephane Bancel told the Financial Times. “I think it’s going to be a material drop,” he … Read more
Nov. 19, 2021 — Everyone over the age of 18 should be allowed to receive a booster of their COVID-19 vaccines, according to a panel of experts that advises CDC on its vaccine recommendations. The Advisory Committee on Immunization Practices, or ACIP, recommended that all adults be eligible for a third dose of a Pfizer … Read more
By Robert Preidt and Robin Foster HealthDay Reporter MONDAY, Nov. 1, 2021 (HealthDay News) — The U.S. Food and Drug Administration has delayed a decision on whether to approve emergency use of Moderna’s COVID-19 vaccine in 12- to 17-year-olds until at least January, the company announced Sunday. That’s because the agency told the company … Read more
JOHN WHYTE: Welcome, everyone. You’re watching Coronavirus in Context. I’m Doctor John White, the Chief Medical Officer at WebMD. So who exactly needs boosters and when? When are we actually going to see a vaccine for kids? And should you wait as a parent for a little while once they’re available? And then, what’s the … Read more
From October 4, the UK will have only one list of countries — red. (File) The UK’s updated Covid-19 travel rules place Indians inoculated with Covishield in the ‘unvaccinated’ category. While the country has relaxed the regulations for those with two doses of the Oxford-AstraZeneca jab, the same version being manufactured in India Serum Institute … Read more
WHO supports studies based on neutralizing antibody tests as they are critical for understanding infection’s extent and risk factors. By Jatin Mahajan, US Centre for Disease Control has recommended a 3rd dose of the Pfizer and Moderna Covid-19 vaccine for developing adequate antibodies amongst immunocompromised people. Some experts recommend a 3rd dose of Covishield six … Read more
A third dose has been recommended for moderately or severely immunocompromised people — believed to be more at risk of serious, prolonged illness The protection against SARS-CoV-2 offered by Pfizer and Moderna’s vaccines wanes over time, according to three new studies by the US Centers for Disease Control and Prevention (CDC), sparking debate among health … Read more
Healthcare has today become more accessible and affordable with the use of modern technological interventions like artificial intelligence (AI), nano-technology, data analytics The first day of FE Healthcare Summit which began on August 18, 2021 concluded with deliberations and panel discussions on subjects ranging from digital health, India’s massive COVID-19 vaccine program: the accessibility strategy, … Read more